Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge ; volume:35 ; number:01 ; year:2014 ; pages:17-20
Indian journal of medical & paediatric oncology ; 35, Heft 01 (2014), 17-20
- Beteiligte Personen und Organisationen
-
Pandey, Avinash
Bhosale, Bharat
Pandita, Vimal
Singh, Ashish
Ghosh, Joydeep
Ghosh, Jaya
Bajpai, Jyoti
- DOI
-
10.4103/0971-5851.133705
- URN
-
urn:nbn:de:101:1-2021083013113655921254
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pandey, Avinash
- Bhosale, Bharat
- Pandita, Vimal
- Singh, Ashish
- Ghosh, Joydeep
- Ghosh, Jaya
- Bajpai, Jyoti
Ähnliche Objekte (12)
Management of relapsed ovarian cancer: a review
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Anaphylactic reaction to carboplatin diagnosed by skin testing—a reliable tool in platinum-based immediate-type hypersensitivity reactions
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Drug hypersensitivity
Hypersensitivity pneumonitis
Oral Challenge without Penicillin Skin Tests in Children with Suspected Beta-Lactam Hypersensitivity
Management of relapsed ovarian cancer: a review
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Anaphylactic reaction to carboplatin diagnosed by skin testing—a reliable tool in platinum-based immediate-type hypersensitivity reactions
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Drug hypersensitivity
Hypersensitivity pneumonitis
Oral Challenge without Penicillin Skin Tests in Children with Suspected Beta-Lactam Hypersensitivity
Management of relapsed ovarian cancer: a review
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Anaphylactic reaction to carboplatin diagnosed by skin testing—a reliable tool in platinum-based immediate-type hypersensitivity reactions
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Drug hypersensitivity
Hypersensitivity pneumonitis